C vs ERNA
Citigroup Inc. (C) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
C currently screens at market cap $214.73B and trailing P/E 15.5. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the C and ERNA stock pages for the full models.
Not investment advice.